查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1923850

锗-68市场按应用程式、产品类型、最终用户和通路划分－2026-2032年全球预测

Germanium 68 Market by Application, Product Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年锗-68 市值将达到 4.4261 亿美元，到 2026 年将成长至 4.9387 亿美元，到 2032 年将达到 9.3794 亿美元，复合年增长率为 11.32%。

关键市场统计数据
基准年 2025 4.4261亿美元
预计年份：2026年 4.9387亿美元
预测年份 2032 9.3794亿美元
复合年增长率 (%) 11.32%

全面介绍锗-68在临床影像、放射性药物工作流程和研究基础设施中的策略作用

锗-68在诊断影像、放射性药物生产和研究应用中发挥着至关重要的作用，它是镓-68生产的母体放射性核素，也是校准和测试流程中的密封源。此同位素的重要性体现在其崩坏特性以及与发生器系统的兼容性上，这些系统能够现场生产短寿命正电子发射体（PET），从而有助于在临床和科研环境中及时获得放射性示踪剂。 PET设备的科技进步，以及对标靶诊断日益增长的需求，使得了解锗-68的运作、监管和供应链等各个方面对于医疗保健、工业和学术界的相关人员至关重要。

成像技术创新、在局部示踪剂生产和供应链现代化将如何重塑锗-68的取得和使用

影像技术的创新、放射性药物研发管线的不断发展以及对增强区域供应韧性的日益重视，正在推动锗-68领域发生变革性变化。 PET成像硬体和软体的进步正在拓展镓-68衍生放射性示踪剂的临床效用，从而增加了对可靠的发生器系统和密封放射源的需求。同时，模组化和照护现场化学平台的出现正在改变医疗机构的现场生产方式，缩短示踪剂的前置作业时间，并实现更灵活的临床排期。

评估2025年美国关税调整及其对锗-68相关人员业务营运、采购和供应连续性的影响

透过关税调整实施的政策措施会对放射性核种供应链的采购、定价和营运规划产生连锁反应。 2025年美国关税调整将为依赖进口发生器组件和密封源材料的机构带来显着的复杂性。某些进口材料关税的提高迫使製造商和最终用户重新审视供应商合同，考虑近岸外包方案，并加强达成能够降低成本波动的长期协议。这些适应性措施对于防止临床服务和研究活动中断至关重要，因为即使是短期中断也可能损害患者照护和实验的连续性。

基于深度细分的洞察，将应用程式、产品类型、最终用户和分销管道连结起来，从而推动可执行的采购和服务优先排序。

深入的市场区隔揭示了不同应用领域如何驱动产品和分销偏好。进一步的分析揭示了临床、工业和研究领域之间微妙的相互依存关係。按应用领域划分，市场涵盖工业测试（包括材料分析和无损检测）、医学影像（涵盖PET和SPECT，包括心臟病学、神经病学和肿瘤学等PET亚专科）、製药生产（专注于放射性示踪剂製造）以及研发（包括学术研究和製药研究）。这些应用领域影响着对发生器和密封源产品的需求，影响着对交货服务水准的期望，并塑造与特定应用场景相关的合规性要求。

区域分析突显了美洲、欧洲、中东和非洲以及亚太地区在监管、物流和临床应用模式方面的差异及其战略意义。

区域趋势导致了不同的管理体制、物流实际情况和临床实施模式，进而影响锗-68及其衍生的采购和部署方式。在美洲，先进的临床网路和集中式卓越中心推动了对高品质产生器系统和可靠分销服务的需求，而法规结构和国内製造能力则影响对进口和本地资源的依赖程度。美洲地区也表现出对营运效率和放射药学服务在医院系统中整合的强烈偏好，这影响了对发生器维护、技术支援和培训服务的选择。

对锗68产业参与者的竞争格局进行分析，重点在于技术差异化、监管合规性和服务品质。

竞争格局包括製造商、发生器系统开发商、密封源製造商、专业分销商以及专注于法规遵循、培训和技术支援的服务供应商。市场参与企业透过投资发生器技术来提高产量可靠性，透过建立延长发生器使用寿命的机制，以及透过建立简化监管核准和临床实施的品质保证系统来实现差异化竞争。技术供应商与放射性药物药房或诊断成像网路之间的策略联盟日益普遍，从而能够协调部署新的示踪剂功能，并为先进的诊断实施提供风险共用模式。

为产业领导者提供切实可行的建议，以增强其供应链的韧性、监管应对力、客户支援和协作创新能力

为确保业务连续性并推动成长，产业领导者应优先考虑三管齐下的策略，以平衡供应链韧性、合规性和以客户为中心的服务创新。首先，加强供应商多元化策略并建立灵活的库存管理政策，将降低关税波动、运输中断和零件短缺带来的风险，同时为临床和研究使用者提供可预测的营运保障。其次，积极与监管机构沟通并投资于全面的合规文件，将缩短新设备的部署时间，并支持跨境分销，从而为区域扩张和伙伴关係的建立铺平道路。

我们采用透明的调查方法，结合关键相关人员访谈、监管分析和技术文献，为我们的实用见解和操作建议提供支援。

本分析基于结构化的调查方法，该方法整合了对设备製造商、放射性药物运营商、临床用户和物流供应商的访谈，并辅以对监管指南、技术标准和同行评审出版物的文献综述。调查方法强调定性见解和技术评估的三角验证，以获得反映锗-68衍生产品在处理、分销和临床应用方面的实际操作情况和当前最佳实践的见解。保密访谈提供了不同最终使用者所采用的筹资策略、维护作业和风险管理方法的背景资讯。

总之，综合分析强调了策略合作、健全的采购体系和增强的服务对于确保锗-68的可靠利用的重要性。

总之，锗-68仍将是临床影像和研究应用中的关键同位素，其策略重要性将受到技术进步、法规环境变化以及当前供应链决策的影响。 PET技术的进步、放射性药物研发管线的不断发展以及对供应链韧性的重视，凸显了製造商、经销商、临床机构和研究机构之间开展合作的必要性。投资于采购多元化、严格合规体系和提升服务水准的相关人员，将更有能力掌握机会，同时最大限度地降低营运风险。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依应用分類的锗-68市场

  • 工业测试
    • 材料分析
    • 无损检测
  • 医学影像
    • PET影像
      • 心臟病学
      • 神经病学
      • 肿瘤学
    • SPECT影像
  • 製药生产
  • 研究与开发
    • 学术研究
    • 药物研究

9. 依产品类型分類的锗 68 市场

  • 放射性药物产生器
    • 68Ge/68Ga产生器
    • 68Ge/68mGa产生器
  • 密封辐射源
    • 可重复使用原始码
    • 一次性酱汁

第十章 依最终用户分類的锗-68市场

  • 诊断中心
    • 诊断影像中心
    • PET中心
  • 医院和诊所
    • 私立医院
    • 公立医院
  • 製药公司
  • 研究所
    • 政府实验室
    • 大学

第十一章 锗68市场通路

  • 离线
  • 在线的

第十二章 锗68市场区域划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 锗68市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 锗68 各国市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 美国锗68市场

第十六章：中国的锗68市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advanced Accelerator Applications
  • ANSTO
  • BWXT Medical Ltd.
  • China Isotope & Radiation Corporation
  • Curium Pharma
  • Eckert & Ziegler AG
  • IRE ELiT
  • ITM Isotope Technologies Munich SE
  • JSC Karpov Institute of Physical Chemistry
  • Mallinckrodt plc
  • Nihon Medi-Physics Co., Ltd.
  • NorthStar Medical Radioisotopes LLC
  • Polatom
  • RadioMedix, Inc.
Product Code: MRR-7A380DA7C2F1

The Germanium 68 Market was valued at USD 442.61 million in 2025 and is projected to grow to USD 493.87 million in 2026, with a CAGR of 11.32%, reaching USD 937.94 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 442.61 million
Estimated Year [2026] USD 493.87 million
Forecast Year [2032] USD 937.94 million
CAGR (%) 11.32%

Comprehensive introduction to the strategic role of germanium-68 across clinical imaging, radiopharmaceutical workflows, and research infrastructures

Germanium-68 occupies a pivotal role across diagnostic imaging, radiopharmaceutical production, and research applications, serving as a parent radionuclide for gallium-68 generation and as a sealed source in calibration and testing workflows. The isotope's relevance is driven by its decay characteristics and compatibility with generator systems that enable onsite production of short-lived positron emitters, facilitating timely access to radiotracers for clinical and research settings. Given the convergence of technological advances in PET instrumentation and growing demand for targeted diagnostics, understanding the operational, regulatory, and supply-chain dimensions of germanium-68 is essential for stakeholders across healthcare, industry, and academia.

In this introduction, primary attention is placed on the isotope's functional roles and the ecosystem that supports its lifecycle, from generator manufacturing and sealed-source production to distribution and end-user handling. Key operational considerations include regulatory compliance for radioactive materials, transport logistics under stringent safety regimes, and the rise of specialized distribution channels that influence accessibility. By framing the discussion around technological utility, application breadth, and the infrastructure required for safe handling, this section establishes the analytical foundation for subsequent sections that explore shifts in landscape, tariff impacts, segmentation insights, and regional dynamics.

How innovations in imaging, localized tracer production, and supply chain modernization are reshaping access and utilization of germanium-68

The landscape for germanium-68 is undergoing transformative shifts driven by innovation in imaging modalities, evolving radiopharmaceutical pipelines, and heightened emphasis on localized supply resilience. Advances in PET imaging hardware and software have expanded the clinical utility of radiotracers derived from gallium-68, which in turn elevates demand for reliable generator systems and sealed sources. Concurrently, the emergence of modular and point-of-care radiochemistry platforms is changing how facilities approach onsite production, reducing lead times for tracer availability and enabling more flexible clinical scheduling.

Supply-chain modernization is also reshaping the market, with specialized distributors and direct-sales models competing to deliver safe, compliant, and timely shipments of radioactive materials. Regulatory harmonization efforts in certain jurisdictions aim to streamline approvals and transport, yet variations across regions continue to influence procurement strategies. Additionally, shifts in R&D priorities-particularly the proliferation of oncology, cardiology, and neurology tracers-are reinforcing the strategic importance of germanium-68 as an enabler of next-generation diagnostics. These converging dynamics compel stakeholders to reassess sourcing strategies, quality assurance protocols, and partnerships across manufacturing, logistics, and clinical operations.

Assessment of the 2025 United States tariff adjustments and their operational, procurement, and supply continuity implications for germanium-68 stakeholders

Policy measures introduced through tariff adjustments can ripple across procurement, pricing, and operational planning for radionuclide supply chains, and the United States tariff changes in 2025 have introduced notable complexity for organizations reliant on imported generator components and sealed-source materials. Increased duties on certain imported materials have prompted manufacturers and end users to revisit supplier contracts, explore nearshoring alternatives, and intensify efforts to secure long-term agreements that mitigate cost volatility. These adaptive responses are essential in maintaining uninterrupted clinical services and research activities where even short disruptions can compromise patient care and experimental continuity.

Beyond immediate procurement implications, the tariff environment has encouraged strategic rebalancing of inventory policies and contingency planning. Clinical operators and radiopharmaceutical producers are reevaluating inventory buffers, certification pathways for domestic suppliers, and collaborative models that share risk across regional partners. In parallel, manufacturers have accelerated dialogues with regulators to ensure that alternate sourcing or component substitution meets safety and performance requirements, maintaining the integrity of generator systems and sealed sources. The combined effect is a more cautious, diversified procurement approach that places premium value on supply reliability, regulatory compliance, and transparent supplier traceability.

Deep segmentation-driven insights connecting applications, product types, end users, and distribution channels to practical procurement and service priorities

Insightful segmentation illuminates how distinct application areas drive product and distribution preferences, and a closer look reveals nuanced interdependencies across clinical, industrial, and research domains. Based on application, the market spans industrial testing including material analysis and non-destructive testing, medical imaging covering PET and SPECT with PET sub-specializations in cardiology, neurology, and oncology, pharmaceutical production focused on radiotracer manufacturing, and research and development including academic and pharmaceutical research. These application domains affect demand for generator versus sealed-source products, influence service-level expectations for delivery, and shape compliance needs tied to specific use cases.

Based on product type, differentiation between radiopharmaceutical generators-further segmented into 68Ge/68Ga generators and 68Ge/68mGa generators-and sealed sources categorized as reusable or single-use informs lifecycle management and total cost of ownership considerations. Generator-based workflows favor facilities with robust radiochemistry capabilities, while sealed sources are often preferred in calibration and industrial test scenarios where repeatable activity profiles are required. Based on end user, diagnostic centers including imaging and PET centers, hospitals and clinics across private and public sectors, pharmaceutical manufacturers focused on radiopharmaceutical production, and research institutes such as government labs and universities each have distinct procurement priorities, regulatory obligations, and technical support needs. Finally, distribution channel dynamics-direct sales, distributors including general and specialized distributors, and online channels-determine availability, lead times, and the level of technical service provided during and after delivery. Collectively, these segmentation lenses guide product development, service design, and commercial strategies to better align supply with the operational realities of each customer cohort.

Regional analysis highlighting distinct regulatory, logistical, and clinical adoption patterns across Americas, EMEA, and Asia-Pacific and their strategic implications

Regional dynamics introduce distinct regulatory regimes, logistical realities, and clinical adoption patterns that shape how organizations source and deploy germanium-68 and derivative products. In the Americas, advanced clinical networks and concentrated centers of excellence drive demand for high-quality generator systems and robust distribution services, while regulatory frameworks and domestic manufacturing capacities influence reliance on imports versus locally produced sources. The Americas also exhibit a strong orientation toward operational efficiency and integration of radiopharmacy services within hospital systems, which affects preferences for generator maintenance, technical support, and training offerings.

Across Europe, the Middle East, and Africa, heterogeneous regulatory environments and uneven infrastructure development create a mosaic of access levels; some markets demonstrate sophisticated nuclear medicine capabilities with established radiopharmaceutical ecosystems, whereas others prioritize incremental capacity building and partnerships to enable clinical adoption. In Asia-Pacific, rapid expansion of nuclear medicine services, growing investment in healthcare infrastructure, and strong research activity fuel diverse demand across both clinical imaging and radiotracer production. Logistics complexities, transport safety rules, and regional regulatory nuances remain important considerations in all territories, influencing distribution strategies, localization opportunities, and collaborative models between suppliers and regional stakeholders.

Competitive landscape analysis focusing on technological differentiation, regulatory adherence, and service excellence among germanium-68 industry participants

The competitive environment features manufacturers, generator system developers, sealed-source producers, specialized distributors, and service providers focused on regulatory compliance, training, and technical support. Market participants differentiate through investments in generator technology that enhance yield reliability, mechanisms that extend usable lifetimes of generators, and quality-assurance systems that simplify regulatory approvals and clinical adoption. Strategic partnerships between technology providers and radiopharmacies or imaging networks are increasingly common, enabling coordinated rollouts of new tracer capabilities and shared risk models for adoption of advanced diagnostics.

A critical axis of differentiation lies in after-sale support, including installation, preventive maintenance, and training for safe handling of radioactive materials. Companies that provide transparent supply-chain traceability, responsive logistics solutions, and robust documentation to satisfy regulatory inspections tend to build stronger trust with hospitals, diagnostic centers, and research institutes. Moreover, players that engage in collaborative research with academic centers or pharmaceutical firms contribute to innovation pipelines, reinforcing their reputational positioning and opening avenues for co-development of new generator chemistries or sealed-source applications.

Actionable recommendations for industry leaders to strengthen resilience, regulatory readiness, customer support, and collaborative innovation across the supply chain

Industry leaders should prioritize a three-pronged approach that balances supply resilience, regulatory alignment, and customer-centric service innovations to safeguard continuity and foster growth. First, strengthening supplier diversification strategies and establishing flexible inventory policies will mitigate exposure to tariff fluctuations, transport disruptions, and component shortages, while enabling more predictable operations for clinical and research users. Second, proactive engagement with regulatory bodies and investment in comprehensive compliance documentation will reduce time-to-deployment for new installations and support cross-border distribution, easing the path for regional expansion and partnerships.

Third, enhancing after-sales support, including targeted training programs for end users, modular maintenance contracts, and remote diagnostics, will increase equipment uptime and customer satisfaction. Leaders should also cultivate collaborative research agreements with academic and pharmaceutical organizations to co-develop next-generation generator systems and radiotracer production methodologies. Finally, incorporating digital tools-such as inventory tracking, shipment monitoring, and online ordering portals-can improve transparency, shorten procurement cycles, and provide analytics that inform capacity planning and product development decisions.

Transparent research methodology combining primary stakeholder interviews, regulatory analysis, and technical literature to underpin actionable insights and operational recommendations

This analysis is built on a structured research approach that integrates primary interviews with equipment manufacturers, radiopharmacy operators, clinical users, and logistics providers, complemented by secondary literature review of regulatory guidance, technical standards, and peer-reviewed publications. The methodology emphasizes triangulation of qualitative insights and technical assessments to ensure findings reflect operational realities and prevailing best practices in handling, distribution, and clinical use of germanium-68 derived products. Confidential interviews provided context on procurement strategies, maintenance practices, and risk management approaches adopted by varied end users.

Data synthesis prioritized cross-validation between practitioner perspectives and documented regulatory frameworks to present balanced conclusions. Case examples drawn from hospital radiopharmacies, industrial testing labs, and research institutes illustrate practical considerations for generator deployment and sealed-source utilization. Limitations include variability in regional regulatory interpretations and the evolving nature of tariff and trade policy, which can alter procurement landscapes; therefore, recommendations remain centered on operational resilience, compliance rigor, and adaptive commercial models that accommodate changing external conditions.

Concluding synthesis emphasizing strategic collaborations, resilient procurement, and service enhancements to secure reliable access to germanium-68 capabilities

In conclusion, germanium-68 continues to be a cornerstone isotope for clinical imaging and research applications, and its strategic importance will be shaped by technological advances, regulatory dynamics, and supply-chain decisions made today. The confluence of improved PET capabilities, evolving radiopharmaceutical pipelines, and a focus on supply resilience highlights the need for coordinated strategies across manufacturers, distributors, clinical operators, and research institutions. Stakeholders that invest in diversified sourcing, rigorous compliance systems, and enhanced service offerings are better positioned to capitalize on opportunities while minimizing operational risk.

Looking ahead, collaboration between industry and clinical research will be crucial to translate generator and sealed-source innovations into routine clinical practice. By adopting adaptive procurement strategies, strengthening technical support frameworks, and engaging proactively with regulators, organizations can ensure continuity of care and accelerate the responsible adoption of next-generation diagnostic tools. The insights in this executive summary are intended to inform strategic decisions, guide operational improvements, and catalyze partnerships that sustain high-quality access to germanium-68 derived capabilities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Germanium 68 Market, by Application

  • 8.1. Industrial Testing
    • 8.1.1. Material Analysis
    • 8.1.2. Non-Destructive Testing
  • 8.2. Medical Imaging
    • 8.2.1. PET Imaging
      • 8.2.1.1. Cardiology
      • 8.2.1.2. Neurology
      • 8.2.1.3. Oncology
    • 8.2.2. SPECT Imaging
  • 8.3. Pharmaceutical Production
  • 8.4. Research & Development
    • 8.4.1. Academic Research
    • 8.4.2. Pharmaceutical Research

9. Germanium 68 Market, by Product Type

  • 9.1. Radiopharmaceutical Generator
    • 9.1.1. 68Ge/68Ga Generators
    • 9.1.2. 68Ge/68mGa Generators
  • 9.2. Sealed Source
    • 9.2.1. Reusable Source
    • 9.2.2. Single Use Source

10. Germanium 68 Market, by End User

  • 10.1. Diagnostic Centers
    • 10.1.1. Imaging Centers
    • 10.1.2. PET Centers
  • 10.2. Hospitals & Clinics
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Pharmaceutical Companies
  • 10.4. Research Institutes
    • 10.4.1. Government Labs
    • 10.4.2. Universities

11. Germanium 68 Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Germanium 68 Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Germanium 68 Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Germanium 68 Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Germanium 68 Market

16. China Germanium 68 Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advanced Accelerator Applications
  • 17.6. ANSTO
  • 17.7. BWXT Medical Ltd.
  • 17.8. China Isotope & Radiation Corporation
  • 17.9. Curium Pharma
  • 17.10. Eckert & Ziegler AG
  • 17.11. IRE ELiT
  • 17.12. ITM Isotope Technologies Munich SE
  • 17.13. JSC Karpov Institute of Physical Chemistry
  • 17.14. Mallinckrodt plc
  • 17.15. Nihon Medi-Physics Co., Ltd.
  • 17.16. NorthStar Medical Radioisotopes LLC
  • 17.17. Polatom
  • 17.18. RadioMedix, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GERMANIUM 68 MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GERMANIUM 68 MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GERMANIUM 68 MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GERMANIUM 68 MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GERMANIUM 68 MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GERMANIUM 68 MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GERMANIUM 68 MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GERMANIUM 68 MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GERMANIUM 68 MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GERMANIUM 68 MARKET SIZE, BY MATERIAL ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GERMANIUM 68 MARKET SIZE, BY MATERIAL ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GERMANIUM 68 MARKET SIZE, BY MATERIAL ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GERMANIUM 68 MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GERMANIUM 68 MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GERMANIUM 68 MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GERMANIUM 68 MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GERMANIUM 68 MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GERMANIUM 68 MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GERMANIUM 68 MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GERMANIUM 68 MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GERMANIUM 68 MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GERMANIUM 68 MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GERMANIUM 68 MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GERMANIUM 68 MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GERMANIUM 68 MARKET SIZE, BY SPECT IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GERMANIUM 68 MARKET SIZE, BY SPECT IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GERMANIUM 68 MARKET SIZE, BY SPECT IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GERMANIUM 68 MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GERMANIUM 68 MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GERMANIUM 68 MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GERMANIUM 68 MARKET SIZE, BY 68GE/68GA GENERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GERMANIUM 68 MARKET SIZE, BY 68GE/68GA GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GERMANIUM 68 MARKET SIZE, BY 68GE/68GA GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GERMANIUM 68 MARKET SIZE, BY 68GE/68MGA GENERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GERMANIUM 68 MARKET SIZE, BY 68GE/68MGA GENERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GERMANIUM 68 MARKET SIZE, BY 68GE/68MGA GENERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GERMANIUM 68 MARKET SIZE, BY REUSABLE SOURCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GERMANIUM 68 MARKET SIZE, BY REUSABLE SOURCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GERMANIUM 68 MARKET SIZE, BY REUSABLE SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GERMANIUM 68 MARKET SIZE, BY SINGLE USE SOURCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GERMANIUM 68 MARKET SIZE, BY SINGLE USE SOURCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GERMANIUM 68 MARKET SIZE, BY SINGLE USE SOURCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GERMANIUM 68 MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GERMANIUM 68 MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GERMANIUM 68 MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GERMANIUM 68 MARKET SIZE, BY PET CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GERMANIUM 68 MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GERMANIUM 68 MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GERMANIUM 68 MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GERMANIUM 68 MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GERMANIUM 68 MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GERMANIUM 68 MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GERMANIUM 68 MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GERMANIUM 68 MARKET SIZE, BY GOVERNMENT LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GERMANIUM 68 MARKET SIZE, BY GOVERNMENT LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GERMANIUM 68 MARKET SIZE, BY GOVERNMENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GERMANIUM 68 MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GERMANIUM 68 MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GERMANIUM 68 MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GERMANIUM 68 MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GERMANIUM 68 MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GERMANIUM 68 MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GERMANIUM 68 MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GERMANIUM 68 MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GERMANIUM 68 MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GERMANIUM 68 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS GERMANIUM 68 MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL GERMANIUM 68 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. GCC GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GCC GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. GCC GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 239. GCC GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 240. GCC GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 241. GCC GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 242. GCC GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. GCC GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 244. GCC GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 245. GCC GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GCC GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 248. GCC GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 249. GCC GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. G7 GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. G7 GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. G7 GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 281. G7 GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 282. G7 GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 283. G7 GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 284. G7 GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. G7 GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 286. G7 GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 287. G7 GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. G7 GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 289. G7 GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 290. G7 GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 291. G7 GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. NATO GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 293. NATO GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. NATO GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 295. NATO GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 296. NATO GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 297. NATO GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 298. NATO GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. NATO GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 300. NATO GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 301. NATO GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. NATO GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 303. NATO GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 304. NATO GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 305. NATO GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 306. GLOBAL GERMANIUM 68 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES GERMANIUM 68 MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA GERMANIUM 68 MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA GERMANIUM 68 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA GERMANIUM 68 MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA GERMANIUM 68 MARKET SIZE, BY MEDICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA GERMANIUM 68 MARKET SIZE, BY PET IMAGING, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA GERMANIUM 68 MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA GERMANIUM 68 MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA GERMANIUM 68 MARKET SIZE, BY RADIOPHARMACEUTICAL GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA GERMANIUM 68 MARKET SIZE, BY SEALED SOURCE, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA GERMANIUM 68 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA GERMANIUM 68 MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA GERMANIUM 68 MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA GERMANIUM 68 MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 334. CHINA GERMANIUM 68 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)